Birchview Capital’s Opko Health OPK Stock Holding History

Birchview Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-103,956	Closed	-$360K	–	54
2018 Q3	$360K	Buy	+103,956	New	+$552K	0.23%	43
2017 Q3	–	Sell	-24,158	Closed	-$159K	–	41
2017 Q2	$159K	Hold	24,158	–	–	0.08%	36
2017 Q1	$193K	Hold	24,158	–	–	0.11%	36
2016 Q4	$225K	Buy	24,158 +3,956	+20%	+$40.9K	0.14%	33
2016 Q3	$214K	Buy	+20,202	New	+$201K	0.12%	35

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Birchview Capital's OPK Position: Q4 2018 in Review

Birchview Capital sold out of Opko Health (OPK) in Q4 2018, closing a stake of 103,956 shares — an estimated $360K sold.

Birchview Capital first reported a position in OPK in Q3 2016 and held it in 5 quarters. The position peaked at $360K in Q3 2018. 202 funds tracked by Wall St. Rank hold OPK as of Q4 2018.

Birchview Capital reported no remaining Opko Health position as of Q4 2018 after selling out during the quarter.
Birchview Capital sold 103,956 Opko Health shares in Q4 2018, an estimated $360K.
Birchview Capital first reported a position in Opko Health in Q3 2016 and held it in 5 quarters.
Birchview Capital's Opko Health position peaked at $360K in Q3 2018.
202 funds tracked by Wall St. Rank held Opko Health as of Q4 2018.

Based on Birchview Capital's 13F filing for Q4 2018, filed 6 Feb 2019.